Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 71 results for "Myelodysplastic Syndromes (MDS)".

Thumbnail for Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

MDS - 1284

Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

Sooraj Srirangadhamu Gopu

Poster Presenter: Sooraj Srirangadhamu Gopu

Thumbnail for Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score-Matched TriNetX Analysis

MDS - 1298

Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score-Matched TriNetX Analysis

Kofi Boakye Opoku

Poster Presenter: Kofi Boakye Opoku

Previous 1 2 3 4 5 6...8 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

MDS - 1311

Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Randomized Treatments for Myelodysplastic Syndrome and Related Disorders: A Comprehensive Component Network Meta-Analysis of Randomized Controlled Trials

MDS - 1343

Randomized Treatments for Myelodysplastic Syndrome and Related Disorders: A Comprehensive Component Network Meta-Analysis of Randomized Controlled Trials

Emi Zerzan

Poster Presenter: Emi Zerzan

Thumbnail for Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

MDS - 1364

Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

Yagna Priya Chirrareddy

Poster Presenter: Yagna Priya Chirrareddy

Thumbnail for Genetic Ancestry Shapes Mutation Prevalence in MDS Patients Beyond Self-Reported Race

MDS - 1378

Genetic Ancestry Shapes Mutation Prevalence in MDS Patients Beyond Self-Reported Race

Chidiebube Ugwu

Poster Presenter: Chidiebube Ugwu

Thumbnail for Updated Incidence Trends in Myelodysplastic Syndrome: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

MDS - 1422

Updated Incidence Trends in Myelodysplastic Syndrome: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

Michael Asare

Poster Presenter: Michael Asare

Thumbnail for Mortality Trends in Older Adults With Myelodysplastic Syndromes and Cardiovascular Disease: A CDC WONDER Analysis (1999-2025)

MDS - 154

Mortality Trends in Older Adults With Myelodysplastic Syndromes and Cardiovascular Disease: A CDC WONDER Analysis (1999-2025)

Priyanka Keshav Lal

Poster Presenter: Priyanka Keshav Lal

Thumbnail for Real-World Outcomes and Prognostic Factors in Chronic Myelomonocytic Leukemia: A Retrospective Single-Center Cohort From Argentina

MDS - 1554

Real-World Outcomes and Prognostic Factors in Chronic Myelomonocytic Leukemia: A Retrospective Single-Center Cohort From Argentina

Julieta De Boeck

Poster Presenter: Julieta De Boeck

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors